TY  - GEN
AU  - Moreira,M A
AU  - Tilbery,C P
AU  - Monteiro,L P
AU  - Teixeira,M M
AU  - Teixeira,A L
TI  - Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis
SN  - 0001-6314
PY  - 2006///1003
KW  - Adult
KW  - Anti-Inflammatory Agents
KW  - pharmacology
KW  - Biomarkers
KW  - blood
KW  - Chemokine CCL2
KW  - Chemokine CXCL10
KW  - Chemokines, CXC
KW  - Chemotaxis, Leukocyte
KW  - immunology
KW  - Controlled Clinical Trials as Topic
KW  - Down-Regulation
KW  - drug effects
KW  - Female
KW  - Humans
KW  - Male
KW  - Methylprednisolone
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Predictive Value of Tests
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1600-0404.2006.00629.x
ER  -